Annual Current Assets
$1.59 M
-$10.97 M-87.34%
31 December 2023
Summary:
CNS Pharmaceuticals annual total current assets is currently $1.59 million, with the most recent change of -$10.97 million (-87.34%) on 31 December 2023. During the last 3 years, it has fallen by -$13.90 million (-89.73%). CNSP annual current assets is now -89.73% below its all-time high of $15.50 million, reached on 31 December 2020.CNSP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$7.39 M
+$5.24 M+244.37%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly total current assets is currently $7.39 million, with the most recent change of +$5.24 million (+244.37%) on 30 September 2024. Over the past year, it has increased by +$5.33 million (+258.33%). CNSP quarterly current assets is now -52.32% below its all-time high of $15.50 million, reached on 31 December 2020.CNSP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -87.3% | +258.3% |
3 y3 years | -89.7% | -33.8% |
5 y5 years | +170.6% | +431.4% |
CNSP Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -89.7% | at low | -49.9% | +364.3% |
5 y | 5 years | -89.7% | +170.6% | -52.3% | +431.4% |
alltime | all time | -89.7% | +881.0% | -52.3% | +1156.3% |
CNS Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $7.39 M(+244.4%) |
June 2024 | - | $2.15 M(+34.0%) |
Mar 2024 | - | $1.60 M(+0.6%) |
Dec 2023 | $109.70 K(-77.5%) | $1.59 M(-22.8%) |
Sept 2023 | - | $2.06 M(-66.0%) |
June 2023 | - | $6.07 M(-12.9%) |
Mar 2023 | - | $6.97 M(-44.5%) |
Dec 2022 | $488.50 K(-61.8%) | $12.56 M(+44.4%) |
Sept 2022 | - | $8.70 M(-23.7%) |
June 2022 | - | $11.40 M(-22.6%) |
Mar 2022 | - | $14.73 M(+97.0%) |
Dec 2021 | $1.28 M | $7.48 M(-33.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $11.16 M(-19.6%) |
June 2021 | - | $13.88 M(+8.6%) |
Mar 2021 | - | $12.79 M(-17.5%) |
Dec 2020 | $357.60 K(+1864.8%) | $15.50 M(+515.8%) |
Sept 2020 | - | $2.52 M(-36.4%) |
June 2020 | - | $3.95 M(-36.1%) |
Mar 2020 | - | $6.19 M(-21.6%) |
Dec 2019 | $18.20 K(-80.9%) | $7.89 M(+467.7%) |
Sept 2019 | - | $1.39 M(-13.2%) |
June 2019 | - | $1.60 M(+172.5%) |
Dec 2018 | $95.20 K(>+9900.0%) | $588.10 K |
Dec 2017 | $0.00 | - |
FAQ
- What is CNS Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual current assets year-on-year change?
- What is CNS Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly current assets year-on-year change?
What is CNS Pharmaceuticals annual total current assets?
The current annual current assets of CNSP is $1.59 M
What is the all time high annual current assets for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual total current assets is $15.50 M
What is CNS Pharmaceuticals annual current assets year-on-year change?
Over the past year, CNSP annual total current assets has changed by -$10.97 M (-87.34%)
What is CNS Pharmaceuticals quarterly total current assets?
The current quarterly current assets of CNSP is $7.39 M
What is the all time high quarterly current assets for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly total current assets is $15.50 M
What is CNS Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, CNSP quarterly total current assets has changed by +$5.33 M (+258.33%)